Status:
COMPLETED
Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
Lead Sponsor:
European Society of Cutaneous Lupus Erythematosus e.V.
Conditions:
Cutaneous Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical manifestations and a variable prognosis. The aim of this study is to create a standardized evaluation of the different...
Detailed Description
Methods: A core set questionnaire has been developed in the course of the "European Society of Cutaneous Lupus Erythematosus (EUSCLE)", and a total of 40 patients (32 females, 8 males) in two centres,...
Eligibility Criteria
Inclusion
- cutaneous lupus erythematosus confirmed by histological analysis
- photoprovocation-test performed in advance
- written informed consent available prior to any procedures
Exclusion
- patients with conditions that are contrary to the above mentioned criteria
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00420173
Start Date
September 1 2004
End Date
June 1 2008
Last Update
December 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Muenster, Department of Dermatology
Münster, North Rhine-Westphalia, Germany, 48149